Central Bank & Trust CO Amgen Inc Transaction History

Central Bank & Trust CO

$708 Million
Q3 2024

A detailed history of Central Bank & Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Central Bank & Trust CO holds 27,515 shares of AMGN stock, worth $7.24 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

27,515

Previous 30,138 8.7%

Holding current value

$7.24 Million

Previous $9.42 Million 5.85%

% of portfolio

1.25%

Previous 1.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $811,503 - $884,947	-2,623 Reduced 8.7%	27,515 $8.87 Million
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $321,343 - $390,516	1,223 Added 4.23%	30,138 $9.42 Million
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $107,548 - $129,824	400 Added 1.4%	28,915 $8.22 Million
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $449,776 - $507,401	1,759 Added 6.57%	28,515 $8.21 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $51,820 - $64,336	-237 Reduced 0.88%	26,756 $7.19 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $160,059 - $189,267	-747 Reduced 2.69%	26,993 $5.99 Million
Q1 2023 Apr 13, 2023	BUY	$225.79 - $275.2 $70,672 - $86,137	313 Added 1.14%	27,740 $6.71 Million
Q4 2022 Jan 18, 2023	SELL	$229.03 - $291.01 $136,501 - $173,441	-596 Reduced 2.13%	27,427 $0
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $207,176 - $233,657	-923 Reduced 3.19%	28,023 $6.32 Million
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $31,145 - $34,659	135 Added 0.47%	28,946 $7.04 Million
Q1 2022 Apr 18, 2022	SELL	$219.27 - $242.57 $137,701 - $152,333	-628 Reduced 2.13%	28,811 $6.97 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $4,972 - $5,690	25 Added 0.08%	29,439 $6.62 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $237,742 - $278,544	1,120 Added 3.96%	29,414 $6.26 Million
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $178,455 - $197,982	764 Added 2.78%	28,294 $6.9 Million
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $20,859 - $24,308	94 Added 0.34%	27,530 $6.85 Million
Q4 2020 Jan 12, 2021	BUY	$216.38 - $257.67 $35,053 - $41,742	162 Added 0.59%	27,436 $6.31 Million
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $185,842 - $206,672	-792 Reduced 2.82%	27,274 $6.93 Million
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $846,626 - $1.04 Million	-4,280 Reduced 13.23%	28,066 $6.62 Million
Q1 2020 Apr 14, 2020	BUY	$182.24 - $241.7 $606,859 - $804,861	3,330 Added 11.48%	32,346 $5.96 Million
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $118,091 - $156,621	-648 Reduced 2.18%	29,016 $5.88 Million
Q4 2019 Jan 13, 2020	SELL	$189.21 - $243.2 $414,369 - $532,608	-2,190 Reduced 6.88%	29,664 $7.15 Million
Q3 2019 Oct 23, 2019	SELL	$174.11 - $208.62 $85,662 - $102,641	-492 Reduced 1.52%	31,854 $6.16 Million
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $615,956 - $722,039	-3,695 Reduced 10.25%	32,346 $5.96 Million
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $185,210 - $208,773	1,024 Added 2.92%	36,041 $6.85 Million
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $69,576 - $81,217	-390 Reduced 1.1%	35,017 $6.82 Million
Q3 2018 Nov 23, 2018	BUY	$185.29 - $208.89 $203,263 - $229,152	1,097 Added 3.2%	35,407 $7.34 Million
Q2 2018 Jul 17, 2018	BUY	$166.05 - $186.51 $991,816 - $1.11 Million	5,973 Added 21.08%	34,310 $6.33 Million
Q1 2018 Apr 27, 2018	BUY	$169.43 - $198.0 $2.84 Million - $3.32 Million	16,745 Added 144.45%	28,337 $4.83 Million
Q4 2017 Jan 16, 2018	BUY	$168.79 - $188.59 $135,369 - $151,249	802 Added 7.43%	11,592 $2.02 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $1.81 Million - $2.06 Million	10,790	10,790 $2.01 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.

Account

Central Bank & Trust CO Amgen Inc Transaction History